Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Swayampakula Ramakanth initiated coverage on Conexeu Sciences Inc (NASDAQ:CNXU) with a Buy rating and announced a price target of $20. Conexeu Sciences shares closed at $13.28 on Thursday. See how other analysts view this stock.
• Evercore ISI Group analyst Mark Lipacis initiated coverage on Credo Technology Group Holding Ltd (NASDAQ:CRDO) with an Outperform rating and announced a price target of $325. Credo Technology shares closed at $271.83 on Thursday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Agomab Therapeutics NV (NASDAQ:AGMB) with a Buy rating and announced a price target of $35. AgomAb Therapeutics shares closed at $10.98 on Thursday. See how other analysts view this stock.
• Keybanc analyst Michael Leshock initiated coverage on Space Exploration Technologies Corp (NASDAQ:SPCX) with a Sector Weight rating. SpaceX shares closed at $185.00 on Thursday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Faeth Therapeutics, Inc. (NASDAQ:FTH) with a Buy rating and announced a price target of $60. Faeth Therapeutics shares closed at $17.82 on Thursday. See how other analysts view this stock.

Considering buying CRDO stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.